The St. Jude Medical Family of Stented Tissue Valves offers optimal implantability and proven long-term durability performance. Building on 30 years of valve leadership, we've collaborated with clinicians to design a revolutionary system — taking implantability to a new level. Our unique stented tissue valve features, with over 25 years of clinical experience, demonstrate our commitment to the practice of cardiac surgery.
Facilitate the implant procedure
- Lowest implant profile
- Valves conform to the annulus
- Mitral ratcheting minimizes potential for suture looping
- Reduce risk of LV outflow tract obstruction in the mitral position
- Reduce risk of aortic wall protrusion
Deliver long-term durability
- Over 25 years clinical experience with Biocor
- Unique triple composite design and FlexFit™ stent reduce stress on leaflets
- Unique pericardial shield minimizes leaflet tissue abrasion
Linx™ AC Technology is a patented, proprietary valve treatment that in animal studies has been demonstrated to resist calcification in four ways:
Reduces free aldehydes1,2
Extracts lipids3
Minimizes uptake of cholesterol4
Stabilizes leaflet collagen4
Extracts lipids3
Minimizes uptake of cholesterol4
Stabilizes leaflet collagen4
There is no clinical data currently available which evaluates the long-term impact of anticalcifaction tissue treatment in humans.
Facilitates the entire Epic and Biocor implant procedures
FlexFit™ Valve Sizers and System Tray
- Click-in handle
- Leading sizer design
FlexFit™ Package Labeling
- Quick, intuitive identification
FlexFit™ Mitral Ratcheting System
- Provides stent deflection
- Maximizes visibility and access to cuff
FlexFit™ Mitral and Aortic Holders
- Improve visibility
FlexFit™ 20 Second Rinse
- Reduced to a 2 x 10 second rinse